PFE Net Income Growth
Pfizer · Net Income Growth
PFE Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-59.69%period ending
PFE TTM Net Income YoY % (13.39% → -59.69%)
Year-over-year change
High-resolution chart · PNG
PFE net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -59.6857% | |
| -4.7795% | |
| -3.1172% | |
| 129.7847% | |
| 514.6934% | |
| 2,831.5972% | |
| 275.8201% | |
| -59.1786% | |
| -112.0638% | |
| -100.9919% | |
| -93.1967% | |
| -64.8268% | |
| -26.6316% | |
| 15.1126% | |
| 41.1148% | |
| 51.2397% | |
| 125.4926% | |
| 136.1356% | |
| 142.6638% | |
| 146.7653% | |
| -8.4232% | |
| -32.1519% | |
| -43.707% | |
| -50.811% | |
| 12.1591% | |
| 37.2026% | |
| 45.911% | |
| -31.927% | |
| -43.8969% | |
| -47.2365% | |
| -47.6653% | |
| 142.8382% | |
| 171.999% | |
| 199.4767% | |
| 196.8241% | |
| 57.3721% | |
| 17.6913% | |
| -4.7232% | |
| 3.1614% | |
| -25.4337% | |
| -20.8207% | |
| -16.9717% | |
| -23.8121% | |
| -20.1852% | |
| -14.4712% | |
| -57.4764% | |
| -58.4988% | |
| -59.3392% | |
| -60.5627% | |
| 39.0531% | |
| 51.0673% | |
| 165.7278% | |
| 157.9323% | |
| 62.0395% | |
| 45.559% | |
| -15.4188% | |
| 19.0498% | |
| 13.3444% | |
| 21.2184% | |
| 86.8275% | |
| 5.426% | |
| 6.5683% | |
| -4.3775% | |
| -24.5881% | |
| 8.1232% | |
| -1.4536% | |
| 6.5523% | |
| -22.9808% | |
| -16.6869% | |
| 6.8499% | |
| -0.4423% | |
| -28.9539% | |
| -48.2251% | |
| -59.5283% | |
| -57.8958% | |
| 17.8266% | |
| 61.0809% | |
| 56.5301% | |
| 139.2402% | |
| 54.343% | |
| 9.2384% | |
| 27.4901% | |
| -28.8394% | |
| -10.4906% | |
| 23.6731% | |
| 492.9434% | |
| 190.5834% | |
| 48.1506% | |
| 27.8025% | |
| -86.701% | |
| -57.1773% | |
| -25.0669% | |
| -20.9864% | |
| 51.2532% | |
| 17.1953% | |
| 13.4464% | |
| 21.5291% | |
| 33.4243% | |
| 52.3577% | |
| 56.1033% |